Form 8-K IRADIMED CORP For: Jul 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Iradimed Corp. (IRMD) Tops Q2 EPS by 2c; Issues Confident Q3 Outlook, Boosts FY15 Guidance
July 30, 2015 9:16 AM EDTIradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $7.6 million versus the consensus estimate of $7.1 million.
Iradimed Corp. sees Q3 2015 EPS of $0.16-$0.17, versus the consensus of $0.13. Iradimed Corp. sees Q3 2015... More
